Peer-Reviewed Journal Articles

Published in Internationally Recognized Peer-Reviewed Journals

Lupus Precision Medicine Products (setting the stage for LuGENE®)

Clinical management of Lupus in the US: a claims-based analysis
Lupus Sci. Med. 11: 1136, 2023.
https://lupus.bmj.com/content/11/Suppl_2/A55.abstract

Addressing Lupus Pillars for Health Advancement (ALPHA) Project: Lupus Clinical Trial Outcome measures and the patient perspective
Lupus Sci. Med. 10: e000901, 2023.
https://lupus.bmj.com/content/10/1/e000901

Recent advances in the use of machine learning and artificial intelligence to improve diagnosis, predict flares and enrich trials in lupus
Curr Opin Rheum 32, 2022.
https://pubmed.ncbi.nlm.nih.gov/36001343/

Diagnosis of Systemic Lupus Erythematosus in the Age of Precision Medicine
Diagnoses Without Names, pp. 77-87, 2022.
https://link.springer.com/chapter/10.1007/978-3-031-04935-4_8/

Increasing ancestral diversity in SLE Clinical Studies ArthritisCare & Research 74: 420-426.
https://onlinelibrary.wiley.com/doi/10.1002/acr.24474

Current Status of the Evaluation and Management of Lupus Patients and Future Prospects
Frontiers in Medicine 8:682544, 2021.
https://www.frontiersin.org/articles/10.3389/fmed.2021.682544/full

Role of ANA testing in the classification of patients with SLE.
Ann. Rheum. Dis 80:e124, 2021.
https://ard.bmj.com/content/80/8/e124

New insights into the role of antinuclear antibodies in SLE.
Nat. Rev. Rheumatol. 16:565, 2020.
https://www.nature.com/articles/s41584-020-0480-7

Current challenges in the development of new treatments for lupus
Ann.Rheum.Dis. 78:729, 2019.
https://ard.bmj.com/content/78/6/729

Biomarkers as entry criteria for clinical trials of new therapies for systemic lupus erythematosus
Arthritis and Rheumatism 69:487, 2017.
https://onlinelibrary.wiley.com/doi/epdf/10.1002/art.40008

Are Autoantibodies the Targets of B Cell Directed Therapy?
Nature Reviews Rheumatology 7: 1610, 2013.

Medical Affairs for LuGENE-Dx®

Increasing Ancestral Diversity in Systemic Lupus Erythematosus Clinical Studies
Arthritis Care Res. 74:420, 2022.
doi: 10.1002/acr.24474.

Deconvoluting the heterogeneity of SLE: the contribution of ancestry
Journal of Allergy and Clinical Immunology, 2021
https://doi.org/10.1016/j.jaci.2021.11.005

Patient  ancestry significantly contributes to molecular heterogeneity of Systemic Lupus Erythematosus
JCI Insights 5(15) e140380, 2020
10.1172/jci.insight.140380.

Engaging African ancestry participants in SLE clinical trials
Lupus Sci. Med. 5:e000297, 2018
doi: 10.1136/lupus-2018-000297.

Pin It on Pinterest